跳至主要内容
临床试验/NCT02789761
NCT02789761Unknown不适用

The Vascular and Cognitive Effects of Chronic High-flavanol Intake in Healthy Males

University of Reading0 个研究点目标入组 34 人开始时间: 2016年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
34
主要终点
Flow-mediated Dilation (FMD)

研究概览

简要总结

A randomised, placebo-controlled, parallel human dietary intervention trial conducted in 33 healthy males to investigate the vascular and cognitive effects of bi-daily consumption of high-flavanol (epicatechin-rich) milk chocolate over a 2-week intervention period. Subjects visited the Hugh Sinclair Unit of Human Nutrition on 3 separate occasions; at the beginning, end and post-intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Body Mass Index 18.5-27.5 kg/m2
  • •Normal Blood pressure (< 150/90)
  • •Non-smoker
  • •Regular exercise routine
  • •Signed consent form

排除标准

  • •Haemoglobin (anaemia marker) < 125 g/l
  • •Gamma GT (liver enzymes) > 80 IU/l
  • •Total Cholesterol > 6.5 mmol/l
  • •Suffered a myocardial infarction or stroke in the last 12 months
  • •Suffers from any cardiovascular or metabolic disorders
  • •Suffers from any blood-clotting disorder, and/or takes supporting medication
  • •Any dietary restrictions or on a weight reducing diet
  • •On any lipid-modifying or blood pressure lowering medication
  • •Consuming any specific vitamin/ herbal supplements or fish oils

研究组 & 干预措施

Low-flavanol milk chocolate

Placebo Comparator

Bi-daily consumption of 12 g portion of a low-flavanol milk chocolate containing approximately <1 mg of (-)-epicatechin for 2-weeks (14 days)

干预措施: Low-flavanol milk chocolate (Dietary Supplement)

High-flavanol milk chocolate

Active Comparator

Bi-daily consumption of 12 g portion of a high-flavanol milk chocolate containing approximately 35 mg of (-)-epicatechin for 2-weeks (14 days)

干预措施: High-flavanol milk choocolate (Dietary Supplement)

结局指标

主要结局

Flow-mediated Dilation (FMD)

时间窗: Change from baseline at 14 days

Ultrasound-based assessment of brachial artery reactivity following induced reactive hyperemia

次要结局

  • Blood pressure (BP)(Change from baseline at 14 days)
  • Plasma Nitrite & Nitrate analysis(Change from baseline at 14 days)
  • Endothelial progenitor cells and Microparticles(Change from baseline at 14 days)
  • Serum analysis of insulin(Change from baseline at 14 days)
  • Plasma flavanol metabolite analysis(Change from baseline at 14 days)
  • Serum analysis of cardivascular-related blood marker(s) concentration(Change from baseline at 14 days)
  • Executive Function(Change from baseline at 14 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeremy Paul Edward Spencer

Professor of Biochemistry

University of Reading

相似试验